跳至主要内容
临床试验/CTRI/2025/11/098015
CTRI/2025/11/098015尚未招募2/3 期

A Controllrd Clinical Study To Evaluate The Efficacy Of Vidanagdi Choorna In Treatment Of Purishaj Krumi With Special Reference To Intestinal Amoebiasis

R.A.Podar Govt(Ayu)College ,worli,Mumbai-181 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年12月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
There is reduction in adhman ,udarshool and frequency of stool . there is eradication of e. histolytica from stool .

研究概览

简要总结

To evaluate the efficacy of vidangadi choorna in purishaj krimi with special reference to intestinal amoebiasis .

STUDY TYPE - Randomised controlled clinical trial

TWO GROUPS -

Trial group - vidangadi choorna ( 3gm twice for 15 days with takra)

 Control group - vrundadi choorna ( 3gm twice for 15 days with takra)

 Objectives -

1.To evaluate the efficacy of vidangadi choorna in intestinal amoebiasis in reducing dravmalpravrutti ,udarshool,adhman .

 2. To evaluate the effect of vidangadi choorna on E.Histolytica in stool routine microscopic examination.

 Design Details - Randomised control clinical trial.

 DURATION -45 days

SAMPLE  SIZE -Total 80 ( 40 for each group)

INCLUSION CRITERIA :-

1, Patients of age group 18-70yrs.

2.sex- all genders

3..patient presenting with sign and symptoms any 2 of following

i.asnhatmalpravrutti

Ii. Adhman

iii.udarshool

3.patient having stool with E.histolytica or their cyst present in stool

EXCLUSION CRITERIA:-

1.Patient having fever, cramping pain,bloody diarrhea .

2.patients having diseases like TB,HIV .

3.pregnant and lactating woman.

  1. patient having fissure or pr bleeding .

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patient Presenting With Sign And Symptom Any 2 of Following 1.Asnhatmalpravrutti 2.Adhman 3.Udarshool Patient Having Stool With E.
  • Histolytica Or Their Cyst Present In Stool .

排除标准

  • 1.Patient Having Fever,Cramping pain, Bloody Diarrhoea.
  • 2.Patient Having Diseases Like TB,HIV.
  • 3.Pregnant And Lactating Women.
  • 4.Patient Having fisure or PR bleeding.

结局指标

主要结局

There is reduction in adhman ,udarshool and frequency of stool . there is eradication of e. histolytica from stool .

时间窗: 15 th day .

次要结局

  • improvement in digestion(45 th day)

研究者

发起方
R.A.Podar Govt(Ayu)College ,worli,Mumbai-18
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Namrata Nanasaheb Dhavan

M.A.Podar Hospital ,R.A.Podar GOVT(Ayu) College ,Worli , Mumbai

研究点 (1)

Loading locations...

相似试验